TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E. Consensus Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Equities
RMDA
EGS381B1C015
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.12 EGP | +0.95% |
|
-4.50% | +28.48% |
Evolution of the average Target Price on Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Price target over the last 5 years
History of analyst recommendation changes
1f7cbf3c1936b525522088.tXi28Jo0I19_Y4TFONQCwnaUCRQhbwc8heME9RrJwpA._iLMhOByTAwwU7yzVJJtgQ7FaCBICW5uyIpPw3yHqefRNfWUyVFCEj4P0Q~7d4cc6c9bb9206cf6132beb9ddcb361a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.12
EGP
Average target price
4.378
EGP
Spread / Average Target
+106.51%
High Price Target
5.7
EGP
Spread / Highest target
+168.87%
Low Price Target
3.42
EGP
Spread / Lowest Target
+61.32%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMDA Stock
- Consensus Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
